nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—type 2 diabetes mellitus—coronary artery disease	0.23	1	CtDrD
Pioglitazone—PPAR alpha—Fenofibrate—coronary artery disease	0.198	0.5	CiPCiCtD
Pioglitazone—PPAR alpha—Gemfibrozil—coronary artery disease	0.198	0.5	CiPCiCtD
Pioglitazone—PPARG—coronary artery disease	0.0569	0.596	CbGaD
Pioglitazone—CYP2C19—coronary artery disease	0.0386	0.404	CbGaD
Pioglitazone—PPARG—Telmisartan—coronary artery disease	0.0157	0.077	CbGbCtD
Pioglitazone—SLCO1B3—Olmesartan—coronary artery disease	0.0116	0.0569	CbGbCtD
Pioglitazone—SLCO1B3—Pitavastatin—coronary artery disease	0.00928	0.0455	CbGbCtD
Pioglitazone—SLCO1B3—Telmisartan—coronary artery disease	0.00928	0.0455	CbGbCtD
Pioglitazone—SLCO1B3—Valsartan—coronary artery disease	0.00903	0.0442	CbGbCtD
Pioglitazone—SLCO1B1—Gemfibrozil—coronary artery disease	0.00713	0.0349	CbGbCtD
Pioglitazone—SLCO1B3—Rosuvastatin—coronary artery disease	0.00684	0.0335	CbGbCtD
Pioglitazone—SLCO1B1—Olmesartan—coronary artery disease	0.00676	0.0331	CbGbCtD
Pioglitazone—SLCO1B3—Pravastatin—coronary artery disease	0.00623	0.0305	CbGbCtD
Pioglitazone—SLCO1B3—Atorvastatin—coronary artery disease	0.00567	0.0278	CbGbCtD
Pioglitazone—SLCO1B1—Pitavastatin—coronary artery disease	0.00541	0.0265	CbGbCtD
Pioglitazone—SLCO1B1—Valsartan—coronary artery disease	0.00526	0.0258	CbGbCtD
Pioglitazone—SLCO1B3—Losartan—coronary artery disease	0.00519	0.0254	CbGbCtD
Pioglitazone—SLCO1B1—Ezetimibe—coronary artery disease	0.00399	0.0195	CbGbCtD
Pioglitazone—SLCO1B1—Rosuvastatin—coronary artery disease	0.00399	0.0195	CbGbCtD
Pioglitazone—CYP2C8—Fenofibrate—coronary artery disease	0.00378	0.0185	CbGbCtD
Pioglitazone—SLCO1B1—Simvastatin—coronary artery disease	0.00371	0.0181	CbGbCtD
Pioglitazone—SLCO1B1—Pravastatin—coronary artery disease	0.00363	0.0178	CbGbCtD
Pioglitazone—SLCO1B1—Lovastatin—coronary artery disease	0.00363	0.0178	CbGbCtD
Pioglitazone—SLCO1B1—Atorvastatin—coronary artery disease	0.0033	0.0162	CbGbCtD
Pioglitazone—SLCO1B1—Losartan—coronary artery disease	0.00302	0.0148	CbGbCtD
Pioglitazone—CYP2C8—Gemfibrozil—coronary artery disease	0.00302	0.0148	CbGbCtD
Pioglitazone—PTGS1—Acetylsalicylic acid—coronary artery disease	0.00285	0.0139	CbGbCtD
Pioglitazone—CYP2C9—Fenofibrate—coronary artery disease	0.00263	0.0129	CbGbCtD
Pioglitazone—CYP2C8—Clopidogrel—coronary artery disease	0.00262	0.0128	CbGbCtD
Pioglitazone—CYP2C19—Gemfibrozil—coronary artery disease	0.00253	0.0124	CbGbCtD
Pioglitazone—CYP2C8—Pitavastatin—coronary artery disease	0.00229	0.0112	CbGbCtD
Pioglitazone—CYP2C19—Clopidogrel—coronary artery disease	0.0022	0.0108	CbGbCtD
Pioglitazone—CYP2C9—Gemfibrozil—coronary artery disease	0.00211	0.0103	CbGbCtD
Pioglitazone—CYP2C19—Telmisartan—coronary artery disease	0.00192	0.0094	CbGbCtD
Pioglitazone—CYP2C9—Clopidogrel—coronary artery disease	0.00183	0.00894	CbGbCtD
Pioglitazone—CYP3A4—Ticagrelor—coronary artery disease	0.00172	0.00841	CbGbCtD
Pioglitazone—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00164	0.00805	CbGbCtD
Pioglitazone—CYP2C9—Pitavastatin—coronary artery disease	0.0016	0.00781	CbGbCtD
Pioglitazone—CYP2C8—Simvastatin—coronary artery disease	0.00157	0.00768	CbGbCtD
Pioglitazone—CYP2C9—Valsartan—coronary artery disease	0.00155	0.0076	CbGbCtD
Pioglitazone—CYP2C19—Timolol—coronary artery disease	0.00155	0.00758	CbGbCtD
Pioglitazone—CYP2C8—Pravastatin—coronary artery disease	0.00153	0.00751	CbGbCtD
Pioglitazone—CYP2C8—Lovastatin—coronary artery disease	0.00153	0.00751	CbGbCtD
Pioglitazone—CYP3A4—Fenofibrate—coronary artery disease	0.00153	0.0075	CbGbCtD
Pioglitazone—CYP2C19—Rosuvastatin—coronary artery disease	0.00141	0.00693	CbGbCtD
Pioglitazone—CYP2C8—Atorvastatin—coronary artery disease	0.0014	0.00684	CbGbCtD
Pioglitazone—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00138	0.00675	CbGbCtD
Pioglitazone—CYP2C19—Simvastatin—coronary artery disease	0.00132	0.00644	CbGbCtD
Pioglitazone—CYP2C19—Lovastatin—coronary artery disease	0.00129	0.0063	CbGbCtD
Pioglitazone—CYP2C8—Losartan—coronary artery disease	0.00128	0.00626	CbGbCtD
Pioglitazone—CYP2D6—Niacin—coronary artery disease	0.00127	0.00619	CbGbCtD
Pioglitazone—CYP3A4—Gemfibrozil—coronary artery disease	0.00122	0.00599	CbGbCtD
Pioglitazone—CYP2C9—cardial valve—coronary artery disease	0.00118	0.363	CbGeAlD
Pioglitazone—CYP2C9—Rosuvastatin—coronary artery disease	0.00118	0.00576	CbGbCtD
Pioglitazone—CYP2D6—Timolol—coronary artery disease	0.00118	0.00576	CbGbCtD
Pioglitazone—CYP2C19—Atorvastatin—coronary artery disease	0.00117	0.00574	CbGbCtD
Pioglitazone—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00115	0.00561	CbGbCtD
Pioglitazone—CYP2C9—Simvastatin—coronary artery disease	0.00109	0.00536	CbGbCtD
Pioglitazone—CYP2C19—Losartan—coronary artery disease	0.00107	0.00525	CbGbCtD
Pioglitazone—CYP2C9—Lovastatin—coronary artery disease	0.00107	0.00524	CbGbCtD
Pioglitazone—CYP2C9—Pravastatin—coronary artery disease	0.00107	0.00524	CbGbCtD
Pioglitazone—CYP3A4—Clopidogrel—coronary artery disease	0.00106	0.0052	CbGbCtD
Pioglitazone—CYP2D6—Captopril—coronary artery disease	0.00104	0.00507	CbGbCtD
Pioglitazone—CYP2D6—Simvastatin—coronary artery disease	0.001	0.0049	CbGbCtD
Pioglitazone—CYP3A4—Eplerenone—coronary artery disease	0.000987	0.00483	CbGbCtD
Pioglitazone—CYP2D6—Pravastatin—coronary artery disease	0.000979	0.00479	CbGbCtD
Pioglitazone—CYP2D6—Lovastatin—coronary artery disease	0.000979	0.00479	CbGbCtD
Pioglitazone—CYP2C9—Atorvastatin—coronary artery disease	0.000975	0.00477	CbGbCtD
Pioglitazone—CYP2C9—Losartan—coronary artery disease	0.000892	0.00437	CbGbCtD
Pioglitazone—CYP2D6—Atorvastatin—coronary artery disease	0.000891	0.00436	CbGbCtD
Pioglitazone—CYP3A4—Enalapril—coronary artery disease	0.00088	0.00431	CbGbCtD
Pioglitazone—CYP3A4—Rosuvastatin—coronary artery disease	0.000684	0.00335	CbGbCtD
Pioglitazone—CYP3A4—Ezetimibe—coronary artery disease	0.000684	0.00335	CbGbCtD
Pioglitazone—CYP3A4—Simvastatin—coronary artery disease	0.000636	0.00311	CbGbCtD
Pioglitazone—CYP3A4—Pravastatin—coronary artery disease	0.000622	0.00305	CbGbCtD
Pioglitazone—CYP3A4—Lovastatin—coronary artery disease	0.000622	0.00305	CbGbCtD
Pioglitazone—CYP3A4—Atorvastatin—coronary artery disease	0.000567	0.00278	CbGbCtD
Pioglitazone—CYP3A4—Losartan—coronary artery disease	0.000518	0.00254	CbGbCtD
Pioglitazone—PPARG—artery—coronary artery disease	0.000303	0.0929	CbGeAlD
Pioglitazone—Rosiglitazone—PPARG—coronary artery disease	0.000269	0.487	CrCbGaD
Pioglitazone—PPARG—endothelium—coronary artery disease	0.000256	0.0785	CbGeAlD
Pioglitazone—Rosiglitazone—CYP2C19—coronary artery disease	0.000182	0.33	CrCbGaD
Pioglitazone—PTGS1—artery—coronary artery disease	0.000162	0.0497	CbGeAlD
Pioglitazone—PPARG—myocardium—coronary artery disease	0.00016	0.049	CbGeAlD
Pioglitazone—PTGS1—endothelium—coronary artery disease	0.000137	0.042	CbGeAlD
Pioglitazone—PPARG—heart—coronary artery disease	0.000112	0.0342	CbGeAlD
Pioglitazone—PPARG—cardiovascular system—coronary artery disease	0.000105	0.0323	CbGeAlD
Pioglitazone—Rosiglitazone—ALB—coronary artery disease	0.000101	0.183	CrCbGaD
Pioglitazone—SLCO1B1—blood—coronary artery disease	9.67e-05	0.0296	CbGeAlD
Pioglitazone—PTGS1—myocardium—coronary artery disease	8.56e-05	0.0262	CbGeAlD
Pioglitazone—PPARG—blood—coronary artery disease	8.34e-05	0.0255	CbGeAlD
Pioglitazone—CYP2C9—heart—coronary artery disease	6.54e-05	0.02	CbGeAlD
Pioglitazone—CYP2C19—blood—coronary artery disease	6.3e-05	0.0193	CbGeAlD
Pioglitazone—CYP2C9—cardiovascular system—coronary artery disease	6.17e-05	0.0189	CbGeAlD
Pioglitazone—PTGS1—heart—coronary artery disease	5.97e-05	0.0183	CbGeAlD
Pioglitazone—PTGS1—cardiovascular system—coronary artery disease	5.64e-05	0.0173	CbGeAlD
Pioglitazone—CYP2C8—blood—coronary artery disease	5.5e-05	0.0168	CbGeAlD
Pioglitazone—PTGS1—cardiac atrium—coronary artery disease	5.11e-05	0.0156	CbGeAlD
Pioglitazone—CYP2C9—blood—coronary artery disease	4.88e-05	0.015	CbGeAlD
Pioglitazone—PTGS1—blood—coronary artery disease	4.46e-05	0.0137	CbGeAlD
Pioglitazone—CYP3A4—blood—coronary artery disease	3.72e-05	0.0114	CbGeAlD
Pioglitazone—CYP2D6—blood—coronary artery disease	3.66e-05	0.0112	CbGeAlD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	2.46e-05	0.000498	CcSEcCtD
Pioglitazone—Urethral disorder—Lisinopril—coronary artery disease	2.46e-05	0.000498	CcSEcCtD
Pioglitazone—Dyspnoea—Niacin—coronary artery disease	2.45e-05	0.000497	CcSEcCtD
Pioglitazone—Insomnia—Pravastatin—coronary artery disease	2.45e-05	0.000497	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Valsartan—coronary artery disease	2.44e-05	0.000495	CcSEcCtD
Pioglitazone—Anaphylactic shock—Perindopril—coronary artery disease	2.44e-05	0.000495	CcSEcCtD
Pioglitazone—Oedema—Perindopril—coronary artery disease	2.44e-05	0.000495	CcSEcCtD
Pioglitazone—Fatigue—Valsartan—coronary artery disease	2.44e-05	0.000495	CcSEcCtD
Pioglitazone—Immune system disorder—Timolol—coronary artery disease	2.44e-05	0.000494	CcSEcCtD
Pioglitazone—Mediastinal disorder—Timolol—coronary artery disease	2.43e-05	0.000493	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Olmesartan—coronary artery disease	2.43e-05	0.000493	CcSEcCtD
Pioglitazone—Dizziness—Acetylsalicylic acid—coronary artery disease	2.43e-05	0.000492	CcSEcCtD
Pioglitazone—Fatigue—Olmesartan—coronary artery disease	2.43e-05	0.000492	CcSEcCtD
Pioglitazone—Hypersensitivity—Fenofibrate—coronary artery disease	2.42e-05	0.00049	CcSEcCtD
Pioglitazone—Dyspnoea—Pravastatin—coronary artery disease	2.42e-05	0.00049	CcSEcCtD
Pioglitazone—Malnutrition—Ramipril—coronary artery disease	2.41e-05	0.000487	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Trandolapril—coronary artery disease	2.4e-05	0.000486	CcSEcCtD
Pioglitazone—Nervous system disorder—Perindopril—coronary artery disease	2.39e-05	0.000485	CcSEcCtD
Pioglitazone—Chest pain—Losartan—coronary artery disease	2.39e-05	0.000484	CcSEcCtD
Pioglitazone—Myalgia—Losartan—coronary artery disease	2.39e-05	0.000484	CcSEcCtD
Pioglitazone—Arthralgia—Losartan—coronary artery disease	2.39e-05	0.000484	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Enalapril—coronary artery disease	2.39e-05	0.000484	CcSEcCtD
Pioglitazone—Urticaria—Simvastatin—coronary artery disease	2.38e-05	0.000483	CcSEcCtD
Pioglitazone—Insomnia—Trandolapril—coronary artery disease	2.38e-05	0.000482	CcSEcCtD
Pioglitazone—Hypersensitivity—Clopidogrel—coronary artery disease	2.38e-05	0.000482	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Niacin—coronary artery disease	2.38e-05	0.000481	CcSEcCtD
Pioglitazone—Anaphylactic shock—Furosemide—coronary artery disease	2.37e-05	0.000481	CcSEcCtD
Pioglitazone—Skin disorder—Perindopril—coronary artery disease	2.37e-05	0.00048	CcSEcCtD
Pioglitazone—Insomnia—Enalapril—coronary artery disease	2.37e-05	0.00048	CcSEcCtD
Pioglitazone—Headache—Rosuvastatin—coronary artery disease	2.37e-05	0.00048	CcSEcCtD
Pioglitazone—Hypersensitivity—Lovastatin—coronary artery disease	2.36e-05	0.000478	CcSEcCtD
Pioglitazone—Hyperhidrosis—Perindopril—coronary artery disease	2.36e-05	0.000478	CcSEcCtD
Pioglitazone—Discomfort—Losartan—coronary artery disease	2.36e-05	0.000478	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Telmisartan—coronary artery disease	2.36e-05	0.000477	CcSEcCtD
Pioglitazone—Asthenia—Fenofibrate—coronary artery disease	2.35e-05	0.000477	CcSEcCtD
Pioglitazone—Malnutrition—Timolol—coronary artery disease	2.35e-05	0.000476	CcSEcCtD
Pioglitazone—Dyspnoea—Trandolapril—coronary artery disease	2.35e-05	0.000475	CcSEcCtD
Pioglitazone—Insomnia—Telmisartan—coronary artery disease	2.34e-05	0.000474	CcSEcCtD
Pioglitazone—Dyspnoea—Enalapril—coronary artery disease	2.34e-05	0.000474	CcSEcCtD
Pioglitazone—Fatigue—Pravastatin—coronary artery disease	2.34e-05	0.000473	CcSEcCtD
Pioglitazone—Nervous system disorder—Furosemide—coronary artery disease	2.33e-05	0.000472	CcSEcCtD
Pioglitazone—Feeling abnormal—Olmesartan—coronary artery disease	2.32e-05	0.00047	CcSEcCtD
Pioglitazone—Hypersensitivity—Ezetimibe—coronary artery disease	2.32e-05	0.000469	CcSEcCtD
Pioglitazone—Asthenia—Clopidogrel—coronary artery disease	2.31e-05	0.000469	CcSEcCtD
Pioglitazone—Muscle spasms—Ramipril—coronary artery disease	2.31e-05	0.000469	CcSEcCtD
Pioglitazone—Dyspnoea—Telmisartan—coronary artery disease	2.31e-05	0.000467	CcSEcCtD
Pioglitazone—Skin disorder—Furosemide—coronary artery disease	2.3e-05	0.000467	CcSEcCtD
Pioglitazone—Asthenia—Lovastatin—coronary artery disease	2.3e-05	0.000466	CcSEcCtD
Pioglitazone—Hyperhidrosis—Furosemide—coronary artery disease	2.29e-05	0.000465	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Captopril—coronary artery disease	2.29e-05	0.000464	CcSEcCtD
Pioglitazone—Anaphylactic shock—Losartan—coronary artery disease	2.29e-05	0.000464	CcSEcCtD
Pioglitazone—Oedema—Losartan—coronary artery disease	2.29e-05	0.000464	CcSEcCtD
Pioglitazone—Infection—Losartan—coronary artery disease	2.27e-05	0.000461	CcSEcCtD
Pioglitazone—Insomnia—Captopril—coronary artery disease	2.27e-05	0.000461	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Trandolapril—coronary artery disease	2.27e-05	0.00046	CcSEcCtD
Pioglitazone—Fatigue—Trandolapril—coronary artery disease	2.27e-05	0.00046	CcSEcCtD
Pioglitazone—Fatigue—Enalapril—coronary artery disease	2.26e-05	0.000458	CcSEcCtD
Pioglitazone—Mediastinal disorder—Lisinopril—coronary artery disease	2.26e-05	0.000458	CcSEcCtD
Pioglitazone—Asthenia—Ezetimibe—coronary artery disease	2.26e-05	0.000457	CcSEcCtD
Pioglitazone—Urticaria—Valsartan—coronary artery disease	2.25e-05	0.000456	CcSEcCtD
Pioglitazone—Diarrhoea—Fenofibrate—coronary artery disease	2.25e-05	0.000455	CcSEcCtD
Pioglitazone—Nervous system disorder—Losartan—coronary artery disease	2.25e-05	0.000455	CcSEcCtD
Pioglitazone—Dyspnoea—Captopril—coronary artery disease	2.24e-05	0.000454	CcSEcCtD
Pioglitazone—Urticaria—Olmesartan—coronary artery disease	2.24e-05	0.000453	CcSEcCtD
Pioglitazone—Feeling abnormal—Pravastatin—coronary artery disease	2.23e-05	0.000453	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Telmisartan—coronary artery disease	2.23e-05	0.000452	CcSEcCtD
Pioglitazone—Ill-defined disorder—Ramipril—coronary artery disease	2.23e-05	0.000452	CcSEcCtD
Pioglitazone—Fatigue—Telmisartan—coronary artery disease	2.23e-05	0.000452	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Perindopril—coronary artery disease	2.22e-05	0.000451	CcSEcCtD
Pioglitazone—Hyperhidrosis—Losartan—coronary artery disease	2.21e-05	0.000448	CcSEcCtD
Pioglitazone—Hypersensitivity—Simvastatin—coronary artery disease	2.21e-05	0.000448	CcSEcCtD
Pioglitazone—Insomnia—Perindopril—coronary artery disease	2.21e-05	0.000447	CcSEcCtD
Pioglitazone—Diarrhoea—Clopidogrel—coronary artery disease	2.21e-05	0.000447	CcSEcCtD
Pioglitazone—Asthenia—Eplerenone—coronary artery disease	2.21e-05	0.000447	CcSEcCtD
Pioglitazone—Angioedema—Ramipril—coronary artery disease	2.2e-05	0.000445	CcSEcCtD
Pioglitazone—Diarrhoea—Lovastatin—coronary artery disease	2.19e-05	0.000444	CcSEcCtD
Pioglitazone—Urticaria—Niacin—coronary artery disease	2.19e-05	0.000443	CcSEcCtD
Pioglitazone—Malnutrition—Lisinopril—coronary artery disease	2.18e-05	0.000442	CcSEcCtD
Pioglitazone—Dyspnoea—Perindopril—coronary artery disease	2.18e-05	0.000441	CcSEcCtD
Pioglitazone—Dizziness—Fenofibrate—coronary artery disease	2.17e-05	0.00044	CcSEcCtD
Pioglitazone—Malaise—Ramipril—coronary artery disease	2.17e-05	0.00044	CcSEcCtD
Pioglitazone—Feeling abnormal—Trandolapril—coronary artery disease	2.17e-05	0.000439	CcSEcCtD
Pioglitazone—Fatigue—Captopril—coronary artery disease	2.17e-05	0.000439	CcSEcCtD
Pioglitazone—Vertigo—Ramipril—coronary artery disease	2.16e-05	0.000438	CcSEcCtD
Pioglitazone—Feeling abnormal—Enalapril—coronary artery disease	2.16e-05	0.000438	CcSEcCtD
Pioglitazone—Urticaria—Pravastatin—coronary artery disease	2.15e-05	0.000436	CcSEcCtD
Pioglitazone—Asthenia—Simvastatin—coronary artery disease	2.15e-05	0.000436	CcSEcCtD
Pioglitazone—Diarrhoea—Ezetimibe—coronary artery disease	2.15e-05	0.000436	CcSEcCtD
Pioglitazone—Flatulence—Lisinopril—coronary artery disease	2.15e-05	0.000436	CcSEcCtD
Pioglitazone—Angioedema—Timolol—coronary artery disease	2.15e-05	0.000435	CcSEcCtD
Pioglitazone—Dizziness—Clopidogrel—coronary artery disease	2.13e-05	0.000432	CcSEcCtD
Pioglitazone—Feeling abnormal—Telmisartan—coronary artery disease	2.13e-05	0.000432	CcSEcCtD
Pioglitazone—Dizziness—Lovastatin—coronary artery disease	2.12e-05	0.000429	CcSEcCtD
Pioglitazone—Vertigo—Timolol—coronary artery disease	2.11e-05	0.000428	CcSEcCtD
Pioglitazone—Back pain—Lisinopril—coronary artery disease	2.11e-05	0.000428	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Perindopril—coronary artery disease	2.11e-05	0.000427	CcSEcCtD
Pioglitazone—Diarrhoea—Eplerenone—coronary artery disease	2.11e-05	0.000427	CcSEcCtD
Pioglitazone—Fatigue—Perindopril—coronary artery disease	2.1e-05	0.000426	CcSEcCtD
Pioglitazone—Muscle spasms—Lisinopril—coronary artery disease	2.1e-05	0.000425	CcSEcCtD
Pioglitazone—Urticaria—Trandolapril—coronary artery disease	2.09e-05	0.000424	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Losartan—coronary artery disease	2.09e-05	0.000423	CcSEcCtD
Pioglitazone—Hypersensitivity—Valsartan—coronary artery disease	2.09e-05	0.000423	CcSEcCtD
Pioglitazone—Urticaria—Enalapril—coronary artery disease	2.08e-05	0.000422	CcSEcCtD
Pioglitazone—Dizziness—Ezetimibe—coronary artery disease	2.08e-05	0.000421	CcSEcCtD
Pioglitazone—Feeling abnormal—Captopril—coronary artery disease	2.07e-05	0.00042	CcSEcCtD
Pioglitazone—Insomnia—Losartan—coronary artery disease	2.07e-05	0.00042	CcSEcCtD
Pioglitazone—Headache—Fenofibrate—coronary artery disease	2.06e-05	0.000417	CcSEcCtD
Pioglitazone—Urticaria—Telmisartan—coronary artery disease	2.05e-05	0.000416	CcSEcCtD
Pioglitazone—Diarrhoea—Simvastatin—coronary artery disease	2.05e-05	0.000416	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Furosemide—coronary artery disease	2.05e-05	0.000415	CcSEcCtD
Pioglitazone—Chest pain—Ramipril—coronary artery disease	2.05e-05	0.000415	CcSEcCtD
Pioglitazone—Arthralgia—Ramipril—coronary artery disease	2.05e-05	0.000415	CcSEcCtD
Pioglitazone—Myalgia—Ramipril—coronary artery disease	2.05e-05	0.000415	CcSEcCtD
Pioglitazone—Fatigue—Furosemide—coronary artery disease	2.05e-05	0.000415	CcSEcCtD
Pioglitazone—Dyspnoea—Losartan—coronary artery disease	2.04e-05	0.000414	CcSEcCtD
Pioglitazone—Dizziness—Eplerenone—coronary artery disease	2.03e-05	0.000412	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	2.03e-05	0.000412	CcSEcCtD
Pioglitazone—Asthenia—Valsartan—coronary artery disease	2.03e-05	0.000412	CcSEcCtD
Pioglitazone—Hypertension—Timolol—coronary artery disease	2.03e-05	0.000411	CcSEcCtD
Pioglitazone—Hypersensitivity—Niacin—coronary artery disease	2.03e-05	0.000411	CcSEcCtD
Pioglitazone—Ill-defined disorder—Lisinopril—coronary artery disease	2.02e-05	0.00041	CcSEcCtD
Pioglitazone—Discomfort—Ramipril—coronary artery disease	2.02e-05	0.00041	CcSEcCtD
Pioglitazone—Asthenia—Olmesartan—coronary artery disease	2.02e-05	0.00041	CcSEcCtD
Pioglitazone—Headache—Clopidogrel—coronary artery disease	2.02e-05	0.00041	CcSEcCtD
Pioglitazone—Anaemia—Lisinopril—coronary artery disease	2.02e-05	0.000409	CcSEcCtD
Pioglitazone—Feeling abnormal—Perindopril—coronary artery disease	2.01e-05	0.000408	CcSEcCtD
Pioglitazone—Headache—Lovastatin—coronary artery disease	2.01e-05	0.000407	CcSEcCtD
Pioglitazone—Arthralgia—Timolol—coronary artery disease	2e-05	0.000406	CcSEcCtD
Pioglitazone—Chest pain—Timolol—coronary artery disease	2e-05	0.000406	CcSEcCtD
Pioglitazone—Myalgia—Timolol—coronary artery disease	2e-05	0.000406	CcSEcCtD
Pioglitazone—Hypersensitivity—Pravastatin—coronary artery disease	2e-05	0.000405	CcSEcCtD
Pioglitazone—Angioedema—Lisinopril—coronary artery disease	1.99e-05	0.000404	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	1.99e-05	0.000403	CcSEcCtD
Pioglitazone—Dizziness—Simvastatin—coronary artery disease	1.98e-05	0.000402	CcSEcCtD
Pioglitazone—Discomfort—Timolol—coronary artery disease	1.98e-05	0.000401	CcSEcCtD
Pioglitazone—Asthenia—Niacin—coronary artery disease	1.97e-05	0.0004	CcSEcCtD
Pioglitazone—Fatigue—Losartan—coronary artery disease	1.97e-05	0.0004	CcSEcCtD
Pioglitazone—Headache—Ezetimibe—coronary artery disease	1.97e-05	0.000399	CcSEcCtD
Pioglitazone—Malaise—Lisinopril—coronary artery disease	1.97e-05	0.000399	CcSEcCtD
Pioglitazone—Anaphylactic shock—Ramipril—coronary artery disease	1.96e-05	0.000398	CcSEcCtD
Pioglitazone—Oedema—Ramipril—coronary artery disease	1.96e-05	0.000398	CcSEcCtD
Pioglitazone—Vertigo—Lisinopril—coronary artery disease	1.96e-05	0.000397	CcSEcCtD
Pioglitazone—Feeling abnormal—Furosemide—coronary artery disease	1.96e-05	0.000396	CcSEcCtD
Pioglitazone—Asthenia—Pravastatin—coronary artery disease	1.94e-05	0.000394	CcSEcCtD
Pioglitazone—Urticaria—Perindopril—coronary artery disease	1.94e-05	0.000393	CcSEcCtD
Pioglitazone—Hypersensitivity—Trandolapril—coronary artery disease	1.94e-05	0.000393	CcSEcCtD
Pioglitazone—Diarrhoea—Valsartan—coronary artery disease	1.94e-05	0.000392	CcSEcCtD
Pioglitazone—Hypersensitivity—Enalapril—coronary artery disease	1.93e-05	0.000391	CcSEcCtD
Pioglitazone—Diarrhoea—Olmesartan—coronary artery disease	1.93e-05	0.000391	CcSEcCtD
Pioglitazone—Headache—Eplerenone—coronary artery disease	1.93e-05	0.000391	CcSEcCtD
Pioglitazone—Nervous system disorder—Ramipril—coronary artery disease	1.93e-05	0.00039	CcSEcCtD
Pioglitazone—Oedema—Timolol—coronary artery disease	1.92e-05	0.000389	CcSEcCtD
Pioglitazone—Anaphylactic shock—Timolol—coronary artery disease	1.92e-05	0.000389	CcSEcCtD
Pioglitazone—Skin disorder—Ramipril—coronary artery disease	1.91e-05	0.000386	CcSEcCtD
Pioglitazone—Infection—Timolol—coronary artery disease	1.91e-05	0.000386	CcSEcCtD
Pioglitazone—Hypersensitivity—Telmisartan—coronary artery disease	1.9e-05	0.000386	CcSEcCtD
Pioglitazone—Hyperhidrosis—Ramipril—coronary artery disease	1.9e-05	0.000385	CcSEcCtD
Pioglitazone—Asthenia—Trandolapril—coronary artery disease	1.89e-05	0.000383	CcSEcCtD
Pioglitazone—Feeling abnormal—Losartan—coronary artery disease	1.89e-05	0.000382	CcSEcCtD
Pioglitazone—Urticaria—Furosemide—coronary artery disease	1.89e-05	0.000382	CcSEcCtD
Pioglitazone—Diarrhoea—Niacin—coronary artery disease	1.88e-05	0.000382	CcSEcCtD
Pioglitazone—Nervous system disorder—Timolol—coronary artery disease	1.88e-05	0.000381	CcSEcCtD
Pioglitazone—Asthenia—Enalapril—coronary artery disease	1.88e-05	0.000381	CcSEcCtD
Pioglitazone—Headache—Simvastatin—coronary artery disease	1.88e-05	0.000381	CcSEcCtD
Pioglitazone—Dizziness—Valsartan—coronary artery disease	1.87e-05	0.000379	CcSEcCtD
Pioglitazone—Skin disorder—Timolol—coronary artery disease	1.86e-05	0.000378	CcSEcCtD
Pioglitazone—Dizziness—Olmesartan—coronary artery disease	1.86e-05	0.000377	CcSEcCtD
Pioglitazone—Arthralgia—Lisinopril—coronary artery disease	1.86e-05	0.000376	CcSEcCtD
Pioglitazone—Myalgia—Lisinopril—coronary artery disease	1.86e-05	0.000376	CcSEcCtD
Pioglitazone—Chest pain—Lisinopril—coronary artery disease	1.86e-05	0.000376	CcSEcCtD
Pioglitazone—Hyperhidrosis—Timolol—coronary artery disease	1.86e-05	0.000376	CcSEcCtD
Pioglitazone—Asthenia—Telmisartan—coronary artery disease	1.86e-05	0.000376	CcSEcCtD
Pioglitazone—Diarrhoea—Pravastatin—coronary artery disease	1.85e-05	0.000376	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	1.84e-05	0.000374	CcSEcCtD
Pioglitazone—Discomfort—Lisinopril—coronary artery disease	1.84e-05	0.000372	CcSEcCtD
Pioglitazone—Dizziness—Niacin—coronary artery disease	1.82e-05	0.000369	CcSEcCtD
Pioglitazone—Urticaria—Losartan—coronary artery disease	1.82e-05	0.000369	CcSEcCtD
Pioglitazone—Asthenia—Captopril—coronary artery disease	1.8e-05	0.000365	CcSEcCtD
Pioglitazone—Diarrhoea—Trandolapril—coronary artery disease	1.8e-05	0.000365	CcSEcCtD
Pioglitazone—Diarrhoea—Enalapril—coronary artery disease	1.79e-05	0.000363	CcSEcCtD
Pioglitazone—Dizziness—Pravastatin—coronary artery disease	1.79e-05	0.000363	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Ramipril—coronary artery disease	1.79e-05	0.000362	CcSEcCtD
Pioglitazone—Oedema—Lisinopril—coronary artery disease	1.78e-05	0.000361	CcSEcCtD
Pioglitazone—Anaphylactic shock—Lisinopril—coronary artery disease	1.78e-05	0.000361	CcSEcCtD
Pioglitazone—Insomnia—Ramipril—coronary artery disease	1.78e-05	0.00036	CcSEcCtD
Pioglitazone—Headache—Valsartan—coronary artery disease	1.77e-05	0.000359	CcSEcCtD
Pioglitazone—Diarrhoea—Telmisartan—coronary artery disease	1.77e-05	0.000358	CcSEcCtD
Pioglitazone—Infection—Lisinopril—coronary artery disease	1.77e-05	0.000358	CcSEcCtD
Pioglitazone—Headache—Olmesartan—coronary artery disease	1.76e-05	0.000358	CcSEcCtD
Pioglitazone—Asthenia—Perindopril—coronary artery disease	1.75e-05	0.000355	CcSEcCtD
Pioglitazone—Dyspnoea—Ramipril—coronary artery disease	1.75e-05	0.000355	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Timolol—coronary artery disease	1.75e-05	0.000354	CcSEcCtD
Pioglitazone—Hypersensitivity—Furosemide—coronary artery disease	1.75e-05	0.000354	CcSEcCtD
Pioglitazone—Dizziness—Trandolapril—coronary artery disease	1.74e-05	0.000353	CcSEcCtD
Pioglitazone—Insomnia—Timolol—coronary artery disease	1.74e-05	0.000352	CcSEcCtD
Pioglitazone—Dizziness—Enalapril—coronary artery disease	1.73e-05	0.000351	CcSEcCtD
Pioglitazone—Skin disorder—Lisinopril—coronary artery disease	1.73e-05	0.00035	CcSEcCtD
Pioglitazone—Headache—Niacin—coronary artery disease	1.72e-05	0.000349	CcSEcCtD
Pioglitazone—Hyperhidrosis—Lisinopril—coronary artery disease	1.72e-05	0.000349	CcSEcCtD
Pioglitazone—Diarrhoea—Captopril—coronary artery disease	1.72e-05	0.000349	CcSEcCtD
Pioglitazone—Dyspnoea—Timolol—coronary artery disease	1.71e-05	0.000347	CcSEcCtD
Pioglitazone—Dizziness—Telmisartan—coronary artery disease	1.71e-05	0.000346	CcSEcCtD
Pioglitazone—Asthenia—Furosemide—coronary artery disease	1.7e-05	0.000345	CcSEcCtD
Pioglitazone—Headache—Pravastatin—coronary artery disease	1.7e-05	0.000344	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Ramipril—coronary artery disease	1.69e-05	0.000343	CcSEcCtD
Pioglitazone—Fatigue—Ramipril—coronary artery disease	1.69e-05	0.000343	CcSEcCtD
Pioglitazone—Hypersensitivity—Losartan—coronary artery disease	1.69e-05	0.000342	CcSEcCtD
Pioglitazone—Diarrhoea—Perindopril—coronary artery disease	1.67e-05	0.000338	CcSEcCtD
Pioglitazone—Dizziness—Captopril—coronary artery disease	1.66e-05	0.000337	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Timolol—coronary artery disease	1.66e-05	0.000336	CcSEcCtD
Pioglitazone—Fatigue—Timolol—coronary artery disease	1.65e-05	0.000335	CcSEcCtD
Pioglitazone—Headache—Trandolapril—coronary artery disease	1.65e-05	0.000334	CcSEcCtD
Pioglitazone—Asthenia—Losartan—coronary artery disease	1.64e-05	0.000333	CcSEcCtD
Pioglitazone—Headache—Enalapril—coronary artery disease	1.64e-05	0.000333	CcSEcCtD
Pioglitazone—Diarrhoea—Furosemide—coronary artery disease	1.62e-05	0.000329	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.62e-05	0.000329	CcSEcCtD
Pioglitazone—Headache—Telmisartan—coronary artery disease	1.62e-05	0.000328	CcSEcCtD
Pioglitazone—Feeling abnormal—Ramipril—coronary artery disease	1.62e-05	0.000328	CcSEcCtD
Pioglitazone—Dizziness—Perindopril—coronary artery disease	1.61e-05	0.000327	CcSEcCtD
Pioglitazone—Insomnia—Lisinopril—coronary artery disease	1.61e-05	0.000326	CcSEcCtD
Pioglitazone—Dyspnoea—Lisinopril—coronary artery disease	1.59e-05	0.000322	CcSEcCtD
Pioglitazone—Feeling abnormal—Timolol—coronary artery disease	1.58e-05	0.00032	CcSEcCtD
Pioglitazone—Headache—Captopril—coronary artery disease	1.58e-05	0.000319	CcSEcCtD
Pioglitazone—Dizziness—Furosemide—coronary artery disease	1.57e-05	0.000318	CcSEcCtD
Pioglitazone—Diarrhoea—Losartan—coronary artery disease	1.57e-05	0.000317	CcSEcCtD
Pioglitazone—Urticaria—Ramipril—coronary artery disease	1.56e-05	0.000316	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.54e-05	0.000311	CcSEcCtD
Pioglitazone—Fatigue—Lisinopril—coronary artery disease	1.54e-05	0.000311	CcSEcCtD
Pioglitazone—Headache—Perindopril—coronary artery disease	1.53e-05	0.00031	CcSEcCtD
Pioglitazone—Urticaria—Timolol—coronary artery disease	1.52e-05	0.000309	CcSEcCtD
Pioglitazone—Dizziness—Losartan—coronary artery disease	1.51e-05	0.000307	CcSEcCtD
Pioglitazone—Headache—Furosemide—coronary artery disease	1.49e-05	0.000301	CcSEcCtD
Pioglitazone—Feeling abnormal—Lisinopril—coronary artery disease	1.47e-05	0.000297	CcSEcCtD
Pioglitazone—Hypersensitivity—Ramipril—coronary artery disease	1.45e-05	0.000293	CcSEcCtD
Pioglitazone—Headache—Losartan—coronary artery disease	1.43e-05	0.000291	CcSEcCtD
Pioglitazone—Urticaria—Lisinopril—coronary artery disease	1.41e-05	0.000287	CcSEcCtD
Pioglitazone—Hypersensitivity—Timolol—coronary artery disease	1.41e-05	0.000287	CcSEcCtD
Pioglitazone—Asthenia—Ramipril—coronary artery disease	1.41e-05	0.000285	CcSEcCtD
Pioglitazone—Asthenia—Timolol—coronary artery disease	1.38e-05	0.000279	CcSEcCtD
Pioglitazone—Diarrhoea—Ramipril—coronary artery disease	1.34e-05	0.000272	CcSEcCtD
Pioglitazone—Diarrhoea—Timolol—coronary artery disease	1.31e-05	0.000266	CcSEcCtD
Pioglitazone—Hypersensitivity—Lisinopril—coronary artery disease	1.31e-05	0.000266	CcSEcCtD
Pioglitazone—Dizziness—Ramipril—coronary artery disease	1.3e-05	0.000263	CcSEcCtD
Pioglitazone—Asthenia—Lisinopril—coronary artery disease	1.28e-05	0.000259	CcSEcCtD
Pioglitazone—Dizziness—Timolol—coronary artery disease	1.27e-05	0.000257	CcSEcCtD
Pioglitazone—Headache—Ramipril—coronary artery disease	1.23e-05	0.000249	CcSEcCtD
Pioglitazone—Diarrhoea—Lisinopril—coronary artery disease	1.22e-05	0.000247	CcSEcCtD
Pioglitazone—Headache—Timolol—coronary artery disease	1.2e-05	0.000244	CcSEcCtD
Pioglitazone—Dizziness—Lisinopril—coronary artery disease	1.18e-05	0.000239	CcSEcCtD
Pioglitazone—Headache—Lisinopril—coronary artery disease	1.12e-05	0.000226	CcSEcCtD
Pioglitazone—CYP2C19—Metabolism—GCLC—coronary artery disease	1.37e-06	6.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CETP—coronary artery disease	1.37e-06	6.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—DCN—coronary artery disease	1.37e-06	6.48e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.36e-06	6.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SDC1—coronary artery disease	1.35e-06	6.43e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—MTHFR—coronary artery disease	1.35e-06	6.43e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—NOS3—coronary artery disease	1.35e-06	6.4e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.34e-06	6.36e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALDH2—coronary artery disease	1.34e-06	6.36e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.33e-06	6.33e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LCAT—coronary artery disease	1.33e-06	6.33e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALDH2—coronary artery disease	1.33e-06	6.31e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOA4—coronary artery disease	1.31e-06	6.21e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HBA1—coronary artery disease	1.31e-06	6.2e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	1.31e-06	6.2e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP2C19—coronary artery disease	1.31e-06	6.2e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LIPC—coronary artery disease	1.31e-06	6.2e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOC3—coronary artery disease	1.3e-06	6.16e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.3e-06	6.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HBA1—coronary artery disease	1.29e-06	6.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP2C19—coronary artery disease	1.29e-06	6.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	1.29e-06	6.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LIPC—coronary artery disease	1.29e-06	6.15e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LDLR—coronary artery disease	1.29e-06	6.13e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOC3—coronary artery disease	1.29e-06	6.11e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AGT—coronary artery disease	1.29e-06	6.1e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PSMA6—coronary artery disease	1.28e-06	6.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PSMB5—coronary artery disease	1.28e-06	6.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LDLR—coronary artery disease	1.28e-06	6.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.28e-06	6.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.28e-06	6.06e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PLCB1—coronary artery disease	1.28e-06	6.06e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTT1—coronary artery disease	1.27e-06	6.05e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC9A1—coronary artery disease	1.27e-06	6.05e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.26e-06	6e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GCLM—coronary artery disease	1.26e-06	6e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC9A1—coronary artery disease	1.26e-06	6e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTT1—coronary artery disease	1.26e-06	6e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CETP—coronary artery disease	1.26e-06	5.98e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GCLC—coronary artery disease	1.26e-06	5.98e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—APOE—coronary artery disease	1.26e-06	5.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.25e-06	5.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CTGF—coronary artery disease	1.25e-06	5.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GCLC—coronary artery disease	1.25e-06	5.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CETP—coronary artery disease	1.25e-06	5.93e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SDC1—coronary artery disease	1.25e-06	5.92e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—APOA1—coronary artery disease	1.25e-06	5.91e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HMGCR—coronary artery disease	1.24e-06	5.88e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GOT2—coronary artery disease	1.24e-06	5.88e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ABCA1—coronary artery disease	1.24e-06	5.87e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SDC1—coronary artery disease	1.24e-06	5.86e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPARG—coronary artery disease	1.23e-06	5.86e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—coronary artery disease	1.23e-06	5.85e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.22e-06	5.81e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.22e-06	5.81e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—POMC—coronary artery disease	1.22e-06	5.78e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.21e-06	5.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GOT1—coronary artery disease	1.2e-06	5.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GGT1—coronary artery disease	1.2e-06	5.69e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.19e-06	5.66e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HADH—coronary artery disease	1.19e-06	5.64e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.19e-06	5.64e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PSMB5—coronary artery disease	1.18e-06	5.59e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PSMA6—coronary artery disease	1.18e-06	5.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PSMA6—coronary artery disease	1.17e-06	5.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PSMB5—coronary artery disease	1.17e-06	5.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.16e-06	5.53e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CTGF—coronary artery disease	1.15e-06	5.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CTGF—coronary artery disease	1.14e-06	5.41e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GOT2—coronary artery disease	1.14e-06	5.41e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HMGCR—coronary artery disease	1.14e-06	5.41e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PLCB1—coronary artery disease	1.14e-06	5.41e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GOT2—coronary artery disease	1.13e-06	5.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HMGCR—coronary artery disease	1.13e-06	5.36e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.13e-06	5.35e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPX2—coronary artery disease	1.13e-06	5.35e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOA2—coronary artery disease	1.13e-06	5.35e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.12e-06	5.31e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.11e-06	5.28e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPX4—coronary artery disease	1.11e-06	5.28e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.11e-06	5.28e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HK1—coronary artery disease	1.11e-06	5.28e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—coronary artery disease	1.11e-06	5.27e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCA1—coronary artery disease	1.1e-06	5.24e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HADHA—coronary artery disease	1.1e-06	5.22e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPARG—coronary artery disease	1.1e-06	5.21e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.09e-06	5.16e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—POMC—coronary artery disease	1.08e-06	5.14e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTP1—coronary artery disease	1.08e-06	5.11e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LPA—coronary artery disease	1.07e-06	5.1e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GGT1—coronary artery disease	1.07e-06	5.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GOT1—coronary artery disease	1.07e-06	5.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	1.07e-06	5.06e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HMOX1—coronary artery disease	1.06e-06	5.04e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NOS3—coronary artery disease	1.06e-06	5.04e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PLCB1—coronary artery disease	1.05e-06	4.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CAT—coronary artery disease	1.05e-06	4.97e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.04e-06	4.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PLCB1—coronary artery disease	1.04e-06	4.93e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOA5—coronary artery disease	1.03e-06	4.89e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.02e-06	4.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOB—coronary artery disease	1.02e-06	4.83e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCA1—coronary artery disease	1.02e-06	4.82e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—P4HB—coronary artery disease	1.01e-06	4.8e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.01e-06	4.78e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	9.92e-07	4.71e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTM1—coronary artery disease	9.89e-07	4.7e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—coronary artery disease	9.87e-07	4.68e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GOT1—coronary artery disease	9.84e-07	4.67e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GGT1—coronary artery disease	9.84e-07	4.67e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GOT1—coronary artery disease	9.75e-07	4.63e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GGT1—coronary artery disease	9.75e-07	4.63e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—LPL—coronary artery disease	9.71e-07	4.61e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—coronary artery disease	9.7e-07	4.61e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTP1—coronary artery disease	9.61e-07	4.56e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	9.52e-07	4.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HMOX1—coronary artery disease	9.47e-07	4.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GPX1—coronary artery disease	9.47e-07	4.5e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NOS3—coronary artery disease	9.44e-07	4.48e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—VCAN—coronary artery disease	9.35e-07	4.44e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CAT—coronary artery disease	9.35e-07	4.44e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALDOA—coronary artery disease	9.28e-07	4.41e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CD36—coronary artery disease	9.22e-07	4.38e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPP2CA—coronary artery disease	9.11e-07	4.32e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOB—coronary artery disease	9.08e-07	4.31e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—DCN—coronary artery disease	9.01e-07	4.28e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—coronary artery disease	8.89e-07	4.22e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTP1—coronary artery disease	8.84e-07	4.2e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTM1—coronary artery disease	8.83e-07	4.19e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALDH2—coronary artery disease	8.76e-07	4.16e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTP1—coronary artery disease	8.76e-07	4.16e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	8.75e-07	4.16e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MTHFR—coronary artery disease	8.74e-07	4.15e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HMOX1—coronary artery disease	8.71e-07	4.14e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	8.68e-07	4.12e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—LPL—coronary artery disease	8.67e-07	4.11e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HMOX1—coronary artery disease	8.64e-07	4.1e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—coronary artery disease	8.63e-07	4.1e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CAT—coronary artery disease	8.6e-07	4.08e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HBA1—coronary artery disease	8.54e-07	4.05e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LIPC—coronary artery disease	8.54e-07	4.05e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	8.54e-07	4.05e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	8.54e-07	4.05e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CAT—coronary artery disease	8.52e-07	4.05e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOC3—coronary artery disease	8.49e-07	4.03e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GPX1—coronary artery disease	8.45e-07	4.01e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LDLR—coronary artery disease	8.43e-07	4e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOB—coronary artery disease	8.35e-07	3.96e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	8.33e-07	3.96e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTT1—coronary artery disease	8.33e-07	3.96e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AGT—coronary artery disease	8.31e-07	3.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOB—coronary artery disease	8.28e-07	3.93e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CETP—coronary artery disease	8.24e-07	3.91e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GCLC—coronary artery disease	8.24e-07	3.91e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CD36—coronary artery disease	8.23e-07	3.91e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SDC1—coronary artery disease	8.15e-07	3.87e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOE—coronary artery disease	8.14e-07	3.86e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPP2CA—coronary artery disease	8.13e-07	3.86e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTM1—coronary artery disease	8.12e-07	3.86e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTM1—coronary artery disease	8.05e-07	3.82e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOA1—coronary artery disease	8.04e-07	3.82e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LPL—coronary artery disease	7.97e-07	3.78e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—coronary artery disease	7.97e-07	3.78e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LPL—coronary artery disease	7.9e-07	3.75e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MTHFR—coronary artery disease	7.8e-07	3.7e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GPX1—coronary artery disease	7.78e-07	3.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GPX1—coronary artery disease	7.71e-07	3.66e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.7e-07	3.66e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PSMA6—coronary artery disease	7.7e-07	3.65e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PSMB5—coronary artery disease	7.7e-07	3.65e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—coronary artery disease	7.58e-07	3.6e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CD36—coronary artery disease	7.57e-07	3.6e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CTGF—coronary artery disease	7.52e-07	3.57e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CD36—coronary artery disease	7.51e-07	3.56e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPP2CA—coronary artery disease	7.48e-07	3.55e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMGCR—coronary artery disease	7.45e-07	3.54e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GOT2—coronary artery disease	7.45e-07	3.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPP2CA—coronary artery disease	7.41e-07	3.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AGT—coronary artery disease	7.41e-07	3.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOE—coronary artery disease	7.26e-07	3.45e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—coronary artery disease	7.26e-07	3.45e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOA1—coronary artery disease	7.18e-07	3.41e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTHFR—coronary artery disease	7.18e-07	3.41e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTHFR—coronary artery disease	7.11e-07	3.38e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARG—coronary artery disease	7.09e-07	3.37e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—POMC—coronary artery disease	6.99e-07	3.32e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.88e-07	3.26e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLCB1—coronary artery disease	6.85e-07	3.25e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AGT—coronary artery disease	6.82e-07	3.24e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AGT—coronary artery disease	6.76e-07	3.21e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOE—coronary artery disease	6.68e-07	3.17e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCA1—coronary artery disease	6.64e-07	3.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOE—coronary artery disease	6.62e-07	3.14e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOA1—coronary artery disease	6.6e-07	3.14e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOA1—coronary artery disease	6.55e-07	3.11e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GGT1—coronary artery disease	6.43e-07	3.05e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GOT1—coronary artery disease	6.43e-07	3.05e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—coronary artery disease	6.37e-07	3.03e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARG—coronary artery disease	6.33e-07	3e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.27e-07	2.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—POMC—coronary artery disease	6.24e-07	2.96e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—coronary artery disease	6.19e-07	2.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NOS3—coronary artery disease	6.1e-07	2.89e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—coronary artery disease	5.97e-07	2.83e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARG—coronary artery disease	5.82e-07	2.76e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTP1—coronary artery disease	5.78e-07	2.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARG—coronary artery disease	5.77e-07	2.74e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—POMC—coronary artery disease	5.74e-07	2.72e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	5.72e-07	2.72e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMOX1—coronary artery disease	5.7e-07	2.71e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—POMC—coronary artery disease	5.69e-07	2.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—coronary artery disease	5.69e-07	2.7e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CAT—coronary artery disease	5.62e-07	2.67e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—coronary artery disease	5.58e-07	2.65e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOB—coronary artery disease	5.46e-07	2.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NOS3—coronary artery disease	5.44e-07	2.58e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—coronary artery disease	5.31e-07	2.52e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTM1—coronary artery disease	5.31e-07	2.52e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—coronary artery disease	5.23e-07	2.48e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LPL—coronary artery disease	5.21e-07	2.47e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—coronary artery disease	5.19e-07	2.46e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPX1—coronary artery disease	5.08e-07	2.41e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NOS3—coronary artery disease	5.01e-07	2.38e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—coronary artery disease	4.98e-07	2.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NOS3—coronary artery disease	4.96e-07	2.36e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CD36—coronary artery disease	4.95e-07	2.35e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.89e-07	2.32e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—coronary artery disease	4.88e-07	2.32e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.69e-07	2.23e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—coronary artery disease	4.58e-07	2.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—coronary artery disease	4.54e-07	2.15e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AGT—coronary artery disease	4.46e-07	2.12e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOE—coronary artery disease	4.37e-07	2.07e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—coronary artery disease	4.34e-07	2.06e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOA1—coronary artery disease	4.32e-07	2.05e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARG—coronary artery disease	3.8e-07	1.81e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—POMC—coronary artery disease	3.75e-07	1.78e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—coronary artery disease	3.43e-07	1.63e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—coronary artery disease	3.42e-07	1.62e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NOS3—coronary artery disease	3.27e-07	1.55e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—coronary artery disease	3.06e-07	1.45e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.99e-07	1.42e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.82e-07	1.34e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—coronary artery disease	2.8e-07	1.33e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—coronary artery disease	2.79e-07	1.33e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—coronary artery disease	2.5e-07	1.19e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—coronary artery disease	2.3e-07	1.09e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—coronary artery disease	2.28e-07	1.08e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.84e-07	8.74e-06	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—coronary artery disease	1.5e-07	7.14e-06	CbGpPWpGaD
